[Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
; 16(4): 341-4, 2002 Dec.
Article
em Zh
| MEDLINE
| ID: mdl-12665900
ABSTRACT
OBJECTIVE:
To generate a candidate HPV16 vaccine for experimental and therapeutical use for cervical cancer.METHODS:
The mutants of HPV16 early E6 and E7 genes were inserted into a vaccinia virus expression vector. A strain of recombinant vaccinia virus was constructed through homologous recombination.RESULTS:
Showed that the mutant E6 and E7 genes were located at TK gene region of vaccinia virus Tiantan strain in a head to head orientation under the control of early/late promoters, H6 and 7.5K respectively. Studies in mice indicated that VmE6E7 could elicit specific antibodies against E6 and E7, and retarded or prevented tumor development in a proportion of C57 BL/6 mice challenged by syngeneic HPV16E6 and E7 transformed tumor cells.CONCLUSIONS:
The success in constructing VmE6E7 provides a basis for the further development of HPV16 therapeutic vaccine.
Buscar no Google
Coleções:
01-internacional
Contexto em Saúde:
4_TD
Base de dados:
MEDLINE
Assunto principal:
Papillomaviridae
/
Proteínas Repressoras
/
Vaccinia virus
/
Proteínas Oncogênicas Virais
/
Genes Virais
/
Vetores Genéticos
/
Neoplasias Experimentais
Tipo de estudo:
Diagnostic_studies
Limite:
Animals
Idioma:
Zh
Revista:
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
Ano de publicação:
2002
Tipo de documento:
Article